Physician profile
Grant Patrick Saxton
NPI 1194111666
$1,105.56
in general payments reported to CMS, 2019-2025
12 companies · $155 in 2025
The $155 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $228 · 2021: $130 · 2022: $59.75 · 2023: $166 · 2024: $201 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $196.22 | 2020-2021 | |
| Glaxosmithkline, LLC. | $186.03 | 2019-2023 | Bexsero, Pediarix |
| Pfizer INC. | $165.57 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $155.57 | 2024-2025 | Qelbree |
| Merck Sharp & Dohme LLC | $118.89 | 2019-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sanofi Pasteur INC. | $98.58 | 2021-2024 | |
| Shire North American Group INC | $59.25 | 2019 | |
| Ironshore Pharmaceuticals INC. | $45.52 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $24.78 | 2023 | Flumist Quadrivalent |
| Corium, LLC | $23.35 | 2023 | Azstarys |
| Collegium Pharmaceutical, INC. | $19.65 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $12.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Saxton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.